Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2397 (LINC02397) is a member of the lincRNA family—a class of autonomously transcribed RNA genes that do not encode proteins and are found in intergenic regions of the genome. These molecules can modulate gene expression directly or through effects on nuclear structure or by scaffolding interactions with proteins, such as chromatin-modifying complexes. While some lincRNAs have roles in cellular differentiation, regulation of transcription, or disease, there is currently no experimentally validated specific function, disease association, or drug interaction known for LINC02397. Further research is needed to clarify if it participates in biological pathways relevant for disease or therapy. In summary, LINC02397 is correctly designated as a lincRNA and not recognized as a therapeutic target, receptor, or biomarker at this time. There is also no evidence of disease implication, drug interaction, or safety concern specifically attached to it in current data.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2397 (LINC02397).